Search
Search Constraints
You searched for: Journal HPBLimit your search
- Journal Article13,914
- HPB [remove]13,914
- Volume 15:(2013)Supplement 12
- Volume 15:(2013)Supplement 29
- Volume 15:Issue 1(2013:Jan.)14
- Volume 15:Issue 10(2013:Oct.)13
- Volume 15:Issue 11(2013:Nov.)14
- Volume 15:Issue 12(2013:Dec.)15
- Volume 15:Issue 2(2013:Feb.)25
- Volume 15:Issue 3(2013:Mar.)14
- Volume 15:Issue 4(2013:Apr.)14
- Volume 15:Issue 5(2013:May)14
- , 327
- Besselink, M. 150
- Aldrighetti, L. 117
- Besselink, M.G. 117
- Vrochides, D. 110
- Pawlik, Timothy M. 89
- Bassi, C. 83
- Ratti, F. 83
- Iannitti, D. 81
- Roberts, K. 81
- 616.362005 13,914
- Biliary tract -- Diseases -- Periodicals 13,914
- Liver -- Diseases -- Periodicals 13,914
- Pancreas -- Diseases -- Periodicals 13,914
- ACS-NSQIP American College of Surgeons National Surgical Quality Improvement Program -- CW Classic Whipple -- DGE Delayed Gastric Emptying -- ISGPS International Study Group for Pancreatic Surgery -- PADC Pancreatic Adenocarcinoma -- PBD Preoperative Biliary Drainage -- PD Pancreaticoduodenectomy -- PJ Pancreaticojejunostomy -- POD Postoperative Day -- POPF Postoperative Pancreatic Fistula -- SSI Surgical Site Infection -- SF Surgery First 1
- AFP alpha fetoprotein -- AIH autoimmune hepatitis -- BMI body mass index -- CIT cold ischemia time -- CI confidence interval -- DBD donor after brain death -- DCD donor after cardiac death -- HR hazard ratio -- HBV hepatitis B virus -- HCV hepatitis C virus -- HCC hepatocellular carcinoma -- IQR interquartile range -- LT liver transplantation -- MELD model for end-stage liver disease -- NASH on-alcoholic steatohepatitis -- OS overall survival -- PBC primary biliary cirrhosis -- PSC primary sclerosing cholangitis -- STAR standard transplant analysis and research -- US United States -- UHN University Health Network -- UNOS United Network for Organ Sharing 1
- AKI acute kidney injury -- KDIGO kidney disease improving global outcomes -- HCC hepatocellular carcinoma -- sCr serum creatinine -- RRT renal replacement therapy -- CKI chronic kidney injury -- eGFR estimated glomerula filtration rate -- ICU intensive care unit -- AUROC area under the receiver operating curve -- OS overall survival -- MELD model for end stage liver disease -- OR odds ratio -- CI confidence interval 1
- Anti-HBc antibody to hepatitis B core antigen -- Anti-HBs antibody to hepatitis B surface antigen -- Anti-HCV antibodies to hepatitis C virus -- cccDNA covalently closed circular DNA -- ddPCR droplet digital polymerase chain reaction -- HBsAg hepatitis B surface antigen -- HBV hepatitis B virus -- HCC hepatocellular carcinoma -- NBNC-HCC non-B, non-C hepatocellular carcinoma 1
- BDTT bile duct tumour thrombus -- HCC hepatocellular carcinoma -- BCLC Barcelona clinical liver cancer -- RR risk ratio -- CI confidence interval -- NOS Newcastle–Ottawa score 1
- Caroli disease -- Liver surgery -- Caroli Syndrome, Intrahepatic bile duct dilation 1